- Home
- ZIMV
ZIMV
ZimVie Inc.
as 01-21-2025 4:00pm EST
ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.
| Founded: | 2021 | Country: | United States |
| Employees: | N/A | City: | PALM BEACH GARDEN |
| Market Cap: | 379.2M | IPO Year: | N/A |
| Target Price: | $19.50 | AVG Volume (30 days): | 112.4K |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -12.84 | EPS Growth: | N/A |
| 52 Week Low/High: | $13.01 - $22.40 | Next Earning Date: | 02-26-2025 |
| Revenue: | $451,294,000 | Revenue Growth: | 267.15% |
| Revenue Growth (this year): | 0.74% | Revenue Growth (next year): | 1.23% |
Latest ZimVie Inc. News
ZIMV Breaking Stock News: Dive into ZIMV Ticker-Specific Updates for Smart Investing
GuruFocus.com
3 months ago
ZimVie Inc (ZIMV) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic Growth ...
Motley Fool
3 months ago
ZimVie (ZIMV) Q3 2024 Earnings Call Transcript
GlobeNewswire
3 months ago
ZimVie Reports Third Quarter 2024 Financial Results
GlobeNewswire
3 months ago
ZimVie to Present at the UBS Global Healthcare Conference
GlobeNewswire
3 months ago
ZimVie to Report Third Quarter Financial Results on October 30, 2024
GuruFocus.com
3 months ago
ZimVie Inc (ZIMV) Q2 2024 Earnings Call Highlights: Navigating Market Challenges with Strategic ...
GuruFocus.com
4 months ago
Neuberger Berman Group LLC's Strategic Acquisition in ZimVie Inc
Motley Fool
6 months ago
ZimVie (ZIMV) Q2 2024 Earnings Call Transcript
Compare ZIMV vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ZIMV ZimVie Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.